Tech Company Financing Transactions

Kardigan Funding Round

Arch Venture Partners, Perceptive Advisors and Sequoia Capital participated in a $300 million Series A venture round for Kardigan. The financing round was announced on 1/13/2025.

Transaction Overview

Company Name
Kardigan
Announced On
1/13/2025
Transaction Type
Venture Equity
Amount
$300,000,000
Round
Series A
Investors

Arch Venture Partners (Lead Investor)

Perceptive Advisors (Lead Investor)

Sequoia Capital (Lead Investor)

Proceeds Purpose
The company intends to use the funds to advance its focus on areas of most unmet need in cardiology, starting with disease opportunities and patient segments that are resistant or poorly managed on current therapies, including primary and secondary cardiomyopathies leading to heart failure.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
131 Oyster Point Blvd. Second Floor
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
www.kardigan.bio
Email Address
Not Recorded
Overview
Reimagining what's possible in cardiovascular medicine: We are a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. Kardigan is on a mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases closer to the cures they deserve.
Profile
Kardigan LinkedIn Company Profile
Social Media
Kardigan Company Twitter Account
Company News
Kardigan News
Facebook
Kardigan on Facebook
YouTube
Kardigan on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tassos Gianakakos
  Tassos Gianakakos LinkedIn Profile  Tassos Gianakakos Twitter Account  Tassos Gianakakos News  Tassos Gianakakos on Facebook
Chief Financial Officer
Brianne Jahn
  Brianne Jahn LinkedIn Profile  Brianne Jahn Twitter Account  Brianne Jahn News  Brianne Jahn on Facebook
Chief Marketing Officer
Emily Faucette
  Emily Faucette LinkedIn Profile  Emily Faucette Twitter Account  Emily Faucette News  Emily Faucette on Facebook
Chief Medical Officer
Jay Edelberg
  Jay Edelberg LinkedIn Profile  Jay Edelberg Twitter Account  Jay Edelberg News  Jay Edelberg on Facebook
Chief Scientific Officer
Bob McDowell
  Bob McDowell LinkedIn Profile  Bob McDowell Twitter Account  Bob McDowell News  Bob McDowell on Facebook
Chief Technical Officer
Donald Mackenzie
  Donald Mackenzie LinkedIn Profile  Donald Mackenzie Twitter Account  Donald Mackenzie News  Donald Mackenzie on Facebook
Vice President
Amy Westfall
  Amy Westfall LinkedIn Profile  Amy Westfall Twitter Account  Amy Westfall News  Amy Westfall on Facebook
VP - General Counsel
Minako Pazdera
  Minako Pazdera LinkedIn Profile  Minako Pazdera Twitter Account  Minako Pazdera News  Minako Pazdera on Facebook
VP - Human Resources
Liz Nguyen
  Liz Nguyen LinkedIn Profile  Liz Nguyen Twitter Account  Liz Nguyen News  Liz Nguyen on Facebook
VP - Regulatory Affairs
Diane Hagerty
  Diane Hagerty LinkedIn Profile  Diane Hagerty Twitter Account  Diane Hagerty News  Diane Hagerty on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/13/2025: Oh venture capital transaction
Next: 1/13/2025: Clear Labs venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.